- Home
- NFE vs VALN Comparison
NFE vs VALN Comparison
Compare NFE & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NFE
- VALN
- Stock Information
- Founded
- NFE 2014
- VALN 2012
- Country
- NFE United States
- VALN France
- Employees
- NFE N/A
- VALN N/A
- Industry
- NFE Oil/Gas Transmission
- VALN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NFE Utilities
- VALN Health Care
- Exchange
- NFE Nasdaq
- VALN Nasdaq
- Market Cap
- NFE 773.2M
- VALN 669.2M
- IPO Year
- NFE 2019
- VALN 2021
- Fundamental
- Price
- NFE $2.31
- VALN $11.53
- Analyst Decision
- NFE Strong Buy
- VALN Strong Buy
- Analyst Count
- NFE 6
- VALN 3
- Target Price
- NFE $8.92
- VALN $15.33
- AVG Volume (30 Days)
- NFE 9.8M
- VALN 96.9K
- Earning Date
- NFE 08-26-2025
- VALN 08-12-2025
- Dividend Yield
- NFE N/A
- VALN N/A
- EPS Growth
- NFE N/A
- VALN N/A
- EPS
- NFE N/A
- VALN N/A
- Revenue
- NFE $2,127,808,000.00
- VALN $230,566,060.00
- Revenue This Year
- NFE $7.43
- VALN $18.61
- Revenue Next Year
- NFE $8.38
- VALN $25.07
- P/E Ratio
- NFE N/A
- VALN N/A
- Revenue Growth
- NFE N/A
- VALN 25.47
- 52 Week Low
- NFE $2.01
- VALN $3.62
- 52 Week High
- NFE $16.66
- VALN $11.53
- Technical
- Relative Strength Index (RSI)
- NFE 36.40
- VALN 77.09
- Support Level
- NFE $2.27
- VALN $10.11
- Resistance Level
- NFE $3.52
- VALN $11.18
- Average True Range (ATR)
- NFE 0.34
- VALN 0.41
- MACD
- NFE -0.10
- VALN 0.35
- Stochastic Oscillator
- NFE 2.17
- VALN 100.00
About NFE New Fortress Energy Inc.
New Fortress Energy Inc is an integrated gas-to-power company. Its business model spans the entire production and delivery chain from natural gas procurement and liquefaction to logistics, shipping, terminals, and conversion or development of a natural gas-fired generation. It has invested in floating, liquefied natural gas vessels to lower the cost of acquiring gas while securing a long-term supply for its terminals. Its segments include Terminals & Infrastructure, and Ships. It generates the majority of its revenue from the Terminals & Infrastructure segment.
About VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.